Abstract
A great attention is presently paid to the design of drug delivery vehicles based on surface-modified magnetic nanoparticles. They can, in principle, be directed to a desired target area for releasing their drug payload, a process triggered by pH, temperature, radiation, or even magnetic field. To this, the possibility of forming part of diagnostic tools by enhanced magnetic resonance imaging or that of further treatment by magnetic hyperthermia can be added. Bare particles are rapidly eliminated from the bloodstream by the phagocyte mononuclear system, leading to short biological half-life. It is hence required to coat them in order to increase their biocompatibility and facilitate the drug incorporation. In this work, magnetite nanoparticles were coated with poly(butylcyanoacrylate) (PBCA) manufactured and characterized with regard to their physical properties and their suitability as a platform for magnetically controlled drug delivery. The average diameter of magnetite and core–shell nanoparticles was 97 ± 19 and 140 ± 20 nm, respectively. Infrared analysis, electrophoretic mobility, surface thermodynamics analysis, and X-ray diffraction all confirmed that the magnetic particles were sufficiently covered by the polymer in the composite nanoparticles. In addition, assays using normal (CCD-18 and MCF-10A) and tumoral (T-84 and MCF-7) cell lines derived from colon and breast tissue, respectively, demonstrated that nanocomposites have low or negligible cytotoxicity. It is concluded that PBCA-coated magnetite core–shell nanoparticles represent a remarkable promise as a platform for magnetically controlled drug delivery.
Similar content being viewed by others
References
Gao J, Gu H, Xu B. Multifunctional magnetic nanoparticles: design, synthesis, and biomedical applications. Acc Chem Res. 2009;42(8):1097–107.
Reddy LH, Arias JL, Nicolas J, Couvreur P. Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. Chem Rev. 2012;112(11):5818–78.
Yan K, Li PH, Zhu HE, Zhou YJ, Ding JD, Shen J, et al. Recent advances in multifunctional magnetic nanoparticles and applications to biomedical diagnosis and treatment. RSC Adv. 2013;3(27):10598–618.
Guo J, Yang W, Wang C. Magnetic colloidal supraparticles: design, fabrication and biomedical applications. Adv Mater. 2013;25(37):5196–214.
Singh A, Sahoo SK. Magnetic nanoparticles: a novel platform for cancer theranostics. Drug Discov Today. 2014;19(4):474–81.
Kalia S, Kango S, Kumar A, Haldorai Y, Kumari B, Kumar R. Magnetic polymer nanocomposites for environmental and biomedical applications. Colloid Polym Sci. 2014:1–28.
El-Hammadi MM, Arias JL. Iron oxide-based multifunctional nanoparticulate systems for biomedical applications: a patent review (2008-present). Expert Opin Ther Pat. 2015;25(6):691–709.
Behrens S, Appel I. Magnetic nanocomposites. Curr Opin Biotechnol. 2016;39:89–96.
Sun C, Lee JS, Zhang M. Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev. 2008;60(11):1252–65.
Sadighian S, Rostamizadeh K, Hosseini-Monfared H, Hamidi M. Doxorubicin-conjugated core-shell magnetite nanoparticles as dual-targeting carriers for anticancer drug delivery. Colloids Surf B Biointerfaces. 2014;117:406–13.
Hilger I. In vivo applications of magnetic nanoparticle hyperthermia. Int J Hyperth. 2013;29(8):828–34.
Dobson J. Magnetic nanoparticles for drug delivery. Drug Develop Res. 2006;67(1):55–60.
Arruebo M, Fernández-Pacheco R, Ibarra MR, Santamaría J. Magnetic nanoparticles for drug delivery. Nano Today. 2007;2(3):22–32.
Arias JL, Reddy LH, Couvreur P. Fe3O4/chitosan nanocomposite for magnetic drug targeting to cancer. J Mater Chem. 2012;22(15):7622–32.
Unsoy G, Yalcin S, Khodadust R, Gunduz G, Gunduz U. Synthesis optimization and characterization of chitosan-coated iron oxide nanoparticles produced for biomedical applications. J Nanopart Res. 2012;14(11):1–13.
Hong RY, Feng B, Chen LL, Liu GH, Li HZ, Zheng Y, et al. Synthesis, characterization and MRI application of dextran-coated Fe3O4 magnetic nanoparticles. Biochem Eng J. 2008;42(3):290–300.
Ruiz A, Salas G, Calero M, Hernández Y, Villanueva A, Herranz F, et al. Short-chain PEG molecules strongly bound to magnetic nanoparticle for MRI long circulating agents. Acta Biomater. 2013;9(5):6421–30.
Peça IN, Bicho A, Gardner R, Cardoso MM. Control of doxorubicin release from magnetic poly(dl-lactide-co-glycolide) nanoparticles by application of a non-permanent magnetic field. J Nanopart Res. 2015;17(11):1–11.
Gao F, Yan Z, Zhou J, Cai Y, Tang J. Methotrexate-conjugated magnetic nanoparticles for thermochemotherapy and magnetic resonance imaging of tumor. J Nanopart Res. 2012;14(10):1–10.
Xu C, Sun S. New forms of superparamagnetic nanoparticles for biomedical applications. Adv Drug Deliv Rev. 2013;65(5):732–43.
Nishio K, Ikeda M, Gokon N, Tsubouchi S, Narimatsu H, Mochizuki Y, et al. Preparation of size-controlled (30–100 nm) magnetite nanoparticles for biomedical applications. J Magn Magn Mater. 2007;310:2408–10.
Stephen ZR, Kievit FM, Zhang M. Magnetite nanoparticles for medical MR imaging. Mater Today (Kidlington). 2011;14(7–8):330–8.
Martínez Vera NP, Schmidt R, Langer K, Zlatev I, Wronski R, Auer E, et al. Tracking of magnetite labeled nanoparticles in the rat brain using MRI. PLoS One. 2014;9(3):e92068.
Sebastianelli A, Sen T, Bruce IJ. Extraction of DNA from soil using nanoparticles by magnetic bioseparation. Lett Appl Microbiol. 2008;46(4):488–91.
Ma C, Li C, He N, Wang F, Ma N, Zhang L, et al. Preparation and characterization of monodisperse core-shell Fe3O4@SiO2 microspheres and its application for magnetic separation of nucleic acids from E. coli BL21. J Biomed Nanotechnol. 2012;8(6):1000–5.
Kempe H, Kempe M. The use of magnetite nanoparticles for implant-assisted magnetic drug targeting in thrombolytic therapy. Biomaterials. 2010;31(36):9499–510.
Ding W, Guo L. Immobilized transferrin Fe3O4@SiO2 nanoparticle with high doxorubicin loading for dual-targeted tumor drug delivery. Int J Nanomedicine. 2013;8:4631–9.
Zamora-Mora V, Fernandez-Gutierrez M, San Roman J, Goya G, Hernandez R, Mijangos C. Magnetic core-shell chitosan nanoparticles: rheological characterization and hyperthermia application. Carbohydr Polym. 2014;102:691–8.
Jaiswal MK, Pradhan A, Banerjee R, Bahadur D. Dual pH and temperature stimuli-responsive magnetic nanohydrogels for thermo-chemotherapy. J Nanosci Nanotechnol. 2014;14(6):4082–9.
Akbarzadeh A, Samiei M, Davaran S. Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine. Nanoscale Res Lett. 2012;7(1):144.
Banerjee SS, Chen DH. Magnetic nanoparticles grafted with cyclodextrin for hydrophobic drug delivery. Chem Mater. 2007;19:6345–9.
Rahimi M, Wadajkar A, Subramanian K, Yousef M, Cui W, Hsieh JT, Nguyen KT. In vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled drug delivery. Nanomedicine. 2010;6(5):672–80.
Khiabani SS, Farshbaf M, Akbarzadeh A, Davaran S. Magnetic nanoparticles: preparation methods, applications in cancer diagnosis and cancer therapy. Artif Cells Nanomed Biotechnol. 2017;45:6–17.
Maeng JH, Lee DH, Jung KH, Bae YH, Park IS, Jeong S, Jeon YS, Shim CK, Kim W, Kim J, Lee J, Lee YM, Kim JH, Kim WH, Hong SS. Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer. Biomaterials. 2010;31(18):4995–5006.
Kaluzova M, Bouras A, Machaidze R, Hadjipanayis CG. Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticles. Oncotarget. 2015;6(11):8788–806.
Amiel GE, Sukhotnik I, Kawar B, Siplovich L. Use of N-butyl-2-cyanoacrylate in elective surgical incisions—longterm outcomes. J Am Coll Surg. 1999;189(1):21–5.
Simeonova M, Ivanova G, Enchev V, Markova N, Kamburov M, Petkov C, et al. Physicochemical characterization and in vitro behavior of daunorubicin-loaded poly(butylcyanoacrylate) nanoparticles. Acta Biomater. 2009;5(6):2109–21.
Ren F, Chen R, Wang Y, Sun Y, Jiang Y, Li G. Paclitaxel-loaded poly(n-butylcyanoacrylate) nanoparticle delivery system to overcome multidrug resistance in ovarian cancer. Pharm Res. 2011;28(4):897–906.
Simeonova M, Rangel M, Ivanova G. NMR study of the supramolecular structure of dual drug-loaded poly(butylcyanoacrylate) nanoparticles. Phys Chem Chem Phys. 2013;15(39):16657–64.
Massart R. Preparation of aqueous magnetic liquids in alkaline and acidic media. IEEE Trans Magn. 1981;17(2):1247–8.
van Oss CJ, Chaudhury MK, Good RJ. Interfacial Lifshitz-van der Waals and polar interactions in macroscopic systems. Chem Rev. 1988;88(6):927–41. doi:10.1021/cr00088a006.
van Oss CJ. Interfacial forces in aqueous media. Second ed. New York: Marcel Dekker Inc.; 2006.
Adamson AW. Physical chemistry of surfaces. Eifth ed. New York: Wiley; 1990.
Qu JB, Shao HH, Jing GL, Huang F. PEG-chitosan-coated iron oxide nanoparticles with high saturated magnetization as carriers of 10-hydroxycamptothecin: preparation, characterization and cytotoxicity studies. Colloids Surf B Biointerfaces. 2013;102:37–44.
Gupta AK, Gupta M. Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles. Biomaterials. 2005;26(13):1565–73.
Zhu L, Ma J, Jia N, Zhao Y, Shen H. Chitosan-coated magnetic nanoparticles as carriers of 5-fluorouracil: preparation, characterization and cytotoxicity studies. Colloids Surf B Biointerfaces. 2009;68(1):1–6.
Yao A, Ai F, Wang D, Huang W, Zhang X. Synthesis, characterization and in vitro cytotoxicity of self-regulating magnetic implant material for hyperthermia application. MAT SCI ENG C-BIO S. 2009;29(8):2525–9.
Arias JL, Gallardo V, Gomez-Lopera SA, Plaza RC, Delgado AV. Synthesis and characterization of poly(ethyl-2-cyanoacrylate) nanoparticles with a magnetic core. J Control Release. 2001;77(3):309–21.
Arias JL, Gallardo V, Linares-Molinero F, Delgado AV. Preparation and characterization of carbonyl iron/poly(butylcyanoacrylate) core/shell nanoparticles. J Colloid Interface Sci. 2006;299(2):599–607.
Shahmabadi HE, Bagherpour Doun SK, Alavi SE, Mortazavi M, Saffari Z, Farahnak M, Akbarzadeh A. An investigation into the parameters affecting preparation of polybuyyl cyanoacrylate nanoparticles by emulsion polymerization. Ind J Clin Biochem. 2014;29:357–61.
Bagad M, Khan ZA. Poly(n-butylcyanoacrylate) nanoaprticles for oral delivery of quercetin: preparation, characterization, and pharmacokinetics and biodistribution studies in Wistar rats. Int J Nanomedicine. 2015;10:3921–35.
Arias JL, Ruiz MA, Lopez-Viota M, Delgado AV. Poly(alkylcyanoacrylate) colloidal particles as vehicles for antitumour drug delivery: a comparative study. Colloid Surf B Biointerf. 2007;52:64–70.
Arias JL, Lopez-Viota M, Ruiz MA, Lopez-Viota J, Delgado AV. Development of carbonyl iron/ethylcellulose core/shell nanoparticles for biomedical applications. Int J Pharm. 2007;339(1–2):237–45.
Arias JL, Reddy LH, Couvreur P. Polymeric nanoparticulate system augmented the anticancer therapeutic efficacy of gemcitabine. J Drug Target. 2009;17:586–98.
Arias JL, Gallardo V, Gómez-Lopera SA, Delgado AV. Loading of 5-fluorouracil to poly(ethyl-2-cyanoacrylate) nanoparticles with a magnetic core. J Biomed Nanotechnol. 2005;1(2):214–23.
Arias JL, Gallardo V, Ruiz MA, Delgado AV. Magnetite/poly(alkylcyanoacrylate) (core/shell) nanoparticles as 5-fluorouracil delivery systems for active targeting. Eur J Pharm Biopharm. 2007;69:54–63.
Arias JL, Gallardo V, Ruiz MA, Delgado AV. Ftorafur loading and controlled release from poly(ethyl-2-cyanoacrylate) and poly(butylcyanoacrylate) nanospheres. Int J Pharm. 2006;337:282–90.
Arias JL. Properties of magnetic colloids to be tailored for drug delivery. In: Arias JL, editor. Drug targeting by magnetically responsive colloids. Hauppauge: Nova Science; 2010. p. 41–55.
Kemp SJ, Ferguson RM, Khandhar AP, Krishnan KM. Monodisperse magnetite nanoparticles with nearly ideal saturation magnetization. RSC Adv. 2016;6:77452–64.
Eslaminejad T, Nematollahi-Mahani SN, Ansari M. Synthesis, characterization, and cytotoxicity of the plasmid EGFP-p53 loaded on pullulan-spermine magnetic nanoparticles. J Magn Magn Mater. 2016;402:34–43.
Xu HL, Mao KL, Huang YP, Yang JJ, Xu J, Chen PP, Fan ZL, Zou S, Gao ZZ, Yin JY, Xiao J, Lu CT, Zhang BL, Zhao YZ. Glioma-targeted superparamagnetic iron oxide nanoparticles as drug-carrying vehicles for theranostic effects. Nanoscale. 2016;8:14222–36.
Wang XQ, Wang L, Tan XR, Zhang HR, Sun GB. Construction of doxorubicin-loading magnetic nanocarriers for assaying apoptosis of glioblastoma cells. J Colloid Interf Sci. 2014;436:267–75.
Huang L, Tao KX, Liu J, Qi C, Xu LM, Chang PP, Gao JB, Shuai XM, Wang GB, Wang Z, Wang L. Design and fabrication of multifunctional sericin nanoparticles for tumor targeting and pH-responsive subcellular delivery of cancer chemotherapy drugs. ACS Appl Mater Interf. 2016;8:6577–85.
Ginzburg VV, Balijepailli S. Modeling the thermodynamics of the interaction of nanoparticles with cell membranes. Nano Lett. 2007;7:3716–22.
Almada M, Burboa MG, Robles E, Gutiérrez LE, Valdés MA, Juárez J. Interaction and cytotoxic effects of hydrophobized chitosan nanoparticles on MDA-MB-231, HeLa and Arpe-19 cell lines. Curr Top Med Chem. 2014;14(6):692–701.
Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev. 2009;61(6):428–37.
Moyano DF, Goldsmith M, Solfiell DJ, Landesman-Milo D, Miranda OR, Peer D, Rotello VM. Nanoparticle hydrophobicity dictates immune response. J Am Chem Soc. 2012;134(9):3965–7.
Owens DE, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm. 2006;307(1):93–102.
Gatoo MA, Naseem S, Arfat MY, Dar AM, Qasim K, Zubair S. Physicochemical properties of nanomaterials: implication in associated toxic manifestations. Biomed Res Int. 2014;2014:498420.
Mahmoudi M, Simchi A, Imani M, Shokrgozar MA, Milani AS, Hafeli UO, et al. A new approach for the in vitro identification of the cytotoxicity of superparamagnetic iron oxide nanoparticles. Colloids Surf B Biointerfaces. 2010;75(1):300–9.
Peng M, Li H, Luo Z, Kong J, Wan Y, Zheng L, et al. Dextran-coated superparamagnetic nanoparticles as potential cancer drug carriers in vivo. Nanoscale. 2015;7(25):11155–62.
Maurizi L, Papa AL, Dumont L, Bouyer F, Walker P, Vandroux D, et al. Influence of surface charge and polymer coating on internalization and biodistribution of polyethylene glycol-modified iron oxide nanoparticles. J Biomed Nanotechnol. 2015;11(1):126–36.
Wang Q, Shen M, Zhao T, Xu Y, Lin J, Duan Y, et al. Low toxicity and long circulation time of polyampholyte-coated magnetic nanoparticles for blood pool contrast agents. Sci Rep. 2015;5:7774.
Acknowledgements
The authors acknowledge the financial support from projects FIS 11/02571 (Instituto de Salud Carlos III, Spain) and PE-2012-FQM-694 (Junta de Andalucía, Spain) and the financial support of the Erasmus Mundus–JOSYLEEM Program in the form of a post-doctoral fellowship to M. El-Hammadi.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
López-Viota, M., El-Hammadi, M.M., Cabeza, L. et al. Development and Characterization of Magnetite/Poly(butylcyanoacrylate) Nanoparticles for Magnetic Targeted Delivery of Cancer Drugs. AAPS PharmSciTech 18, 3042–3052 (2017). https://doi.org/10.1208/s12249-017-0792-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-017-0792-3